Takahashi Toshiaki, Zimmer Julia, Friedmacher Florian, Puri Prem
National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Gate 5, Dublin 12, Dublin, Ireland.
National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Gate 5, Dublin 12, Dublin, Ireland; Conway Institute of Biomolecular and Biomedical Research, School of Medicine & Medical Science, University College Dublin, Belfield, Dublin, 4, Dublin, Ireland.
J Pediatr Surg. 2017 May;52(5):706-709. doi: 10.1016/j.jpedsurg.2017.01.020. Epub 2017 Jan 28.
BACKGROUND/PURPOSE: Pulmonary hypoplasia (PH), characterized by incomplete alveolar development, remains a major therapeutic challenge associated with congenital diaphragmatic hernia (CDH). Follistatin-like 1 (Fstl1) is a crucial regulator of alveolar formation and maturation, which is strongly expressed in distal airway epithelium. Fstl1-deficient mice exhibit reduced airspaces, impaired alveolar epithelial cell differentiation, and insufficient production of surfactant proteins similar to PH in human CDH. We hypothesized that pulmonary Fstl1 expression is decreased during alveolarization in the nitrofen-induced CDH model.
Timed-pregnant rats received nitrofen or vehicle on gestational day 9 (D9). Fetal lungs were harvested on D18 and D21 and divided into control-/nitrofen-exposed specimens. Alveolarization was assessed using morphometric analysis techniques. Pulmonary gene expression of Fstl1 was determined by qRT-PCR. Immunofluorescence-double-staining for Fstl1 and alveolar epithelial marker surfactant protein C (SP-C) was performed to evaluate protein expression/localization.
Radial alveolar count was significantly reduced in hypoplastic lungs of nitrofen-exposed fetuses with significant down regulation of Fstl1 mRNA expression on D18 and D21 compared to controls. Confocal-laser-scanning-microscopy revealed strikingly diminished Fstl1 immunofluorescence and SP-C expression in distal alveolar epithelium of nitrofen-exposed fetuses with CDH-associated PH on D18 and D21 compared to controls.
Decreased expression of Fstl1 in alveolar epithelium may disrupt alveolarization and pulmonary surfactant production, thus contributing to the development of PH in the nitrofen-induced CDH model.
2b (Centre for Evidence-Based Medicine, Oxford).
背景/目的:肺发育不全(PH)以肺泡发育不完全为特征,仍然是与先天性膈疝(CDH)相关的一项主要治疗挑战。卵泡抑素样蛋白1(Fstl1)是肺泡形成和成熟的关键调节因子,在远端气道上皮中强烈表达。Fstl1基因缺陷小鼠表现出肺泡腔减少、肺泡上皮细胞分化受损以及表面活性蛋白产生不足,类似于人类CDH中的PH。我们推测在硝基芬诱导的CDH模型中,肺泡化过程中肺组织Fstl1表达会降低。
在妊娠第9天(D9)给定时怀孕的大鼠给予硝基芬或赋形剂。在D18和D21收集胎儿肺脏,并分为对照/硝基芬暴露标本。使用形态计量分析技术评估肺泡化。通过qRT-PCR测定Fstl1的肺基因表达。进行Fstl1和肺泡上皮标志物表面活性蛋白C(SP-C)的免疫荧光双重染色,以评估蛋白表达/定位。
与对照组相比,暴露于硝基芬的胎儿发育不全肺脏的径向肺泡计数显著降低,且在D18和D21时Fstl1 mRNA表达明显下调。共聚焦激光扫描显微镜显示,与对照组相比,在D18和D21时,患有与CDH相关的PH的硝基芬暴露胎儿的远端肺泡上皮中Fstl1免疫荧光和SP-C表达显著减少。
肺泡上皮中Fstl1表达降低可能会破坏肺泡化和肺表面活性物质的产生,从而导致硝基芬诱导的CDH模型中PH的发生。
2b(牛津循证医学中心)